Calumet 公司
CLMT
57.75
-0.49
-0.84%
Calumet 公司
US · CLMT
#2145 按市值排名
上市于 1970
57.75
-0.49
-0.84%
实时 - 追踪5344个代码 - 心跳于231秒前
· 2026-10-16 20:02
✦ 量化股权信号 计算方式说明
涨跌不一/平稳
- 机构持股总比例基本持平。
机构持股
- 机构持股比例
- 70.45% +0.07pp
- 机构数量
- 229
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期增持了股份,同时该股在最近20个交易日的主力资金呈净流入——两者方向一致。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund28.88%
Private Company19.26%
Hedge Fund12.15%
Public Company4.97%
Family Office/Trust4.54%
Individual/Insider3.41%
Government Pension Fund0.53%
Insurance Company0.10%
Other26.14%
主要股东 截至 2026-06-05
The Heritage Group
16.52% · 14.52M 股
Two Seas Capital LP
7.53% · 6.62M 股
BlackRock
5.95% · 5.23M 股
Wasserstein & Co., L.P.
4.51% · 3.96M 股
Vanguard Capital Management, LLC
4.47% · 3.93M 股
State Street Global Advisors
3.95% · 3.47M 股
Adams Asset Advisors LLC
2.28% · 2.01M 股
Geode Capital Management, LLC
2.23% · 1.96M 股
Barclays PLC
1.60% · 1.41M 股
Vanguard Portfolio Management, LLC
1.17% · 1.03M 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 38次买入 · 12次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| The Heritage Group | -- | 16.52% |
| Jennifer Straumins | Director of Calumet GP, LLC | 1.07% |
| Bruce Fleming | Executive Vice President of Montana Renewables & Corporate Development of Calumet GP, LLC | 0.70% |
| Stephen Mawer | Chairman of the Board of Calumet GP, LLC | 0.40% |
| Louis Borgmann | Chief Executive Officer of Calumet GP, LLC | 0.37% |
| Amy Schumacher | Director of Calumet GP, LLC | 0.29% |
| Scott Obermeier | Executive Vice President of Specialties of Calumet GP, LLC | 0.27% |
| Daniel Sajkowski | Director of Calumet GP, LLC | 0.09% |
| Gregory Morical | Senior VP, General Counsel & Secretary of Calumet GP, LLC | 0.07% |
| John Boss | Independent Director of Calumet GP, LLC | 0.04% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-24 | Stephen Mawer | Chairman of the Board of Calumet GP, LLC | Derivative Exercise and Sale | -24,555 | -- |
| 2026-09-24 | Stephen Mawer | Chairman of the Board of Calumet GP, LLC | Derivative Exercise and Retained | +36,832 | -- |
| 2026-09-24 | Bruce Fleming | Executive Vice President of Montana Renewables & Corporate Development of Calumet GP, LLC | Derivative Exercise and Sale | -42,190 | -- |
| 2026-09-24 | Bruce Fleming | Executive Vice President of Montana Renewables & Corporate Development of Calumet GP, LLC | Derivative Exercise and Retained | +65,238 | -- |
| 2026-09-24 | Louis Borgmann | Chief Executive Officer of Calumet GP, LLC | Derivative Exercise and Sale | -46,901 | -- |
| 2026-09-24 | Louis Borgmann | Chief Executive Officer of Calumet GP, LLC | Derivative Exercise and Retained | +60,527 | -- |
| 2026-09-24 | Gregory Morical | Senior VP, General Counsel & Secretary of Calumet GP, LLC | Derivative Exercise and Sale | -13,560 | -- |
| 2026-09-24 | Gregory Morical | Senior VP, General Counsel & Secretary of Calumet GP, LLC | Derivative Exercise and Retained | +17,134 | -- |
| 2026-08-19 | John Boss | Independent Director of Calumet GP, LLC | Other Derivative Acquisition | +53 | -- |
| 2026-08-19 | John Boss | Independent Director of Calumet GP, LLC | Other Derivative Acquisition | +160 | -- |
| 2026-08-19 | Paul Raymond | Director of Calumet GP, LLC | Other Derivative Acquisition | +178 | -- |
| 2026-08-19 | Paul Raymond | Director of Calumet GP, LLC | Other Derivative Acquisition | +534 | -- |
| 2026-08-19 | Stephen Mawer | Chairman of the Board of Calumet GP, LLC | Other Derivative Acquisition | +230 | -- |
| 2026-08-19 | Stephen Mawer | Chairman of the Board of Calumet GP, LLC | Other Derivative Acquisition | +690 | -- |
| 2026-08-19 | Amy Schumacher | Director of Calumet GP, LLC | Other Derivative Acquisition | +162 | -- |
| 2026-08-19 | Amy Schumacher | Director of Calumet GP, LLC | Other Derivative Acquisition | +488 | -- |
| 2026-07-08 | Karen Narwold | Independent Director | Derivative Exercise and Retained | +7,067 | -- |
| 2026-07-08 | Karen Twitchell | Independent Director of Calumet GP, LLC | Derivative Exercise and Retained | +7,067 | -- |
| 2026-07-08 | John Boss | Independent Director of Calumet GP, LLC | Derivative Exercise and Sale | -2,827 | -- |
| 2026-07-08 | John Boss | Independent Director of Calumet GP, LLC | Derivative Exercise and Retained | +4,240 | -- |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 20:02:13 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
Calumet 公司 讨论区 0 条评论